| Original language | English |
|---|---|
| Pages (from-to) | 20-26 |
| Number of pages | 7 |
| Journal | Pharmacological Research |
| Volume | 129 |
| DOIs | |
| Publication status | Published - 2018 |
Keywords
- Angiotensin II receptor blockers
- Antihypertensive drugs
- Carotid intima-media thickness
- Ultrasonography
- amlodipine
- angiotensin receptor antagonist
- atenolol
- biological marker
- candesartan
- doxazosin
- felodipine
- hydrochlorothiazide
- irbesartan
- losartan
- olmesartan
- valsartan
- antihypertensive therapy
- arterial wall thickness
- atherosclerosis
- cardiovascular mortality
- cardiovascular risk
- disease association
- drug effect
- drug efficacy
- echography
- human
- hypertension
- morbidity
- priority journal
- prognosis
- Review
- risk factor
Cite this
Carotid intima-media thickness and anti-hypertensive treatment: Focus on angiotensin II receptor blockers. / Cuspidi, C.; Sala, C.; Tadic, M.; Grassi, G.; Mancia, G.
In: Pharmacological Research, Vol. 129, 2018, p. 20-26.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Carotid intima-media thickness and anti-hypertensive treatment: Focus on angiotensin II receptor blockers
AU - Cuspidi, C.
AU - Sala, C.
AU - Tadic, M.
AU - Grassi, G.
AU - Mancia, G.
N1 - Export Date: 11 September 2018 CODEN: PHMRE Correspondence Address: Cuspidi, C.; Istituto Auxologico Italiano, Clinical Research Unit, Viale della Resistenza 23, Italy; email: cesare.cuspidi@unmib.it
PY - 2018
Y1 - 2018
KW - Angiotensin II receptor blockers
KW - Antihypertensive drugs
KW - Carotid intima-media thickness
KW - Ultrasonography
KW - amlodipine
KW - angiotensin receptor antagonist
KW - atenolol
KW - biological marker
KW - candesartan
KW - doxazosin
KW - felodipine
KW - hydrochlorothiazide
KW - irbesartan
KW - losartan
KW - olmesartan
KW - valsartan
KW - antihypertensive therapy
KW - arterial wall thickness
KW - atherosclerosis
KW - cardiovascular mortality
KW - cardiovascular risk
KW - disease association
KW - drug effect
KW - drug efficacy
KW - echography
KW - human
KW - hypertension
KW - morbidity
KW - priority journal
KW - prognosis
KW - Review
KW - risk factor
U2 - 10.1016/j.phrs.2018.01.007
DO - 10.1016/j.phrs.2018.01.007
M3 - Article
VL - 129
SP - 20
EP - 26
JO - Pharmacological Research
JF - Pharmacological Research
SN - 1043-6618
ER -